Will Austin lose biopharma HQ to Connecticut? It depends on who you ask

Vermillion has experienced a bumpy ride on the Nasdaq in 15-plus years. In 2015, it leased office and lab space in Connecticut, where its CEO and CFO work. Now there are conflicting accounts of whether it plans to shift its headquarters there.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 22, 2018 Category: Pharmaceuticals Authors: Mike Cronin Source Type: news